These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37525589)

  • 1. Corrigendum to "m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency".
    Clin Transl Med; 2023 Aug; 13(8):e1353. PubMed ID: 37525589
    [No Abstract]   [Full Text] [Related]  

  • 2. m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency.
    Li G; Luo R; Zhang W; He S; Wang B; Liang H; Song Y; Ke W; Shi Y; Feng X; Zhao K; Wu X; Zhang Y; Wang K; Yang C
    Clin Transl Med; 2022 Mar; 12(3):e765. PubMed ID: 35340126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma.
    Tang W; Xu N; Zhou J; He Z; Lenahan C; Wang C; Ji H; Liu B; Zou Y; Zeng H; Guo H
    Cell Death Discov; 2022 Dec; 8(1):497. PubMed ID: 36566230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
    Yang Z; Cai Z; Yang C; Luo Z; Bao X
    EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
    Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
    Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
    Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
    J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
    Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
    Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells.
    Luo J; Yu H; Yuan Z; Ye T; Hu B
    Clin Transl Oncol; 2023 Jul; 25(7):2265-2276. PubMed ID: 36820954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
    Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
    Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine hypomethylation of circGPATCH2L regulates DNA damage and apoptosis through TRIM28 in intervertebral disc degeneration.
    Chen Z; Song J; Xie L; Xu G; Zheng C; Xia X; Lu F; Ma X; Zou F; Jiang J; Wang H
    Cell Death Differ; 2023 Aug; 30(8):1957-1972. PubMed ID: 37438603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of RNA M6A demethylase ALKBH5 gene deficiency on morphology and function of cerebellum in aged mice].
    Fei Y; Ma CH; Li Q; Song W; Tong WM; Niu YM
    Zhonghua Bing Li Xue Za Zhi; 2023 Jun; 52(6):606-611. PubMed ID: 37263926
    [No Abstract]   [Full Text] [Related]  

  • 12. Comprehensive analysis of N6-methyladenosine (m
    Zhu B; Chen HX; Li S; Tan JH; Xie Y; Zou MX; Wang C; Xue JB; Li XL; Cao Y; Yan YG
    J Orthop Translat; 2021 Nov; 31():126-138. PubMed ID: 34976732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALKBH5 activates FAK signaling through m6A demethylation in
    Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
    Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
    [No Abstract]   [Full Text] [Related]  

  • 14. ALKBH5-Mediated m6A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer.
    Liu H; Lyu H; Jiang G; Chen D; Ruan S; Liu S; Zhou L; Yang M; Zeng S; He Z; Wang H; Li H; Zheng G; Liu B
    Cancer Res; 2022 Nov; 82(21):3974-3986. PubMed ID: 36069931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA demethylase ALKBH5 promotes tumorigenesis of t (8;21) acute myeloid leukemia via ITPA m6A modification.
    Li R; Wu X; Xue K; Feng D; Li J; Li J
    Biomark Res; 2023 Mar; 11(1):30. PubMed ID: 36899424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD.
    Liu Z; Chen Y; Wang L; Ji S
    Neurochem Res; 2021 Nov; 46(11):3003-3011. PubMed ID: 34297301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner.
    Wang W; Huang Q; Liao Z; Zhang H; Liu Y; Liu F; Chen X; Zhang B; Chen Y; Zhu P
    Exp Hematol Oncol; 2023 Jan; 12(1):1. PubMed ID: 36609413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALKBH5/YTHDF2-mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation.
    Shao Y; Liu Z; Song X; Sun R; Zhou Y; Zhang D; Sun H; Huang J; Wu C; Gu W; Zheng X; Jiang J
    Clin Transl Med; 2023 Jul; 13(7):e1318. PubMed ID: 37381158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ALKBH5 attenuates I/R-induced renal injury in male mice by promoting Ccl28 m6A modification and increasing Treg recruitment.
    Chen J; Xu C; Yang K; Gao R; Cao Y; Liang L; Chen S; Xu S; Rong R; Wang J; Zhu T
    Nat Commun; 2023 Mar; 14(1):1161. PubMed ID: 36859428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m
    Onalan E; Yakar B; Onalan EE; Karakulak K; Kaymaz T; Donder E
    J Coll Physicians Surg Pak; 2022 Sep; 32(9):1143-1148. PubMed ID: 36089710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.